140 related articles for article (PubMed ID: 38720924)
1. Enhancing encapsulation of filarial antigen
Balasubramaniyan M; Vinayagam V; Kizhakedathil MPJ; Perumal K
ADMET DMPK; 2024; 12(2):379-389. PubMed ID: 38720924
[TBL] [Abstract][Full Text] [Related]
2. Immunopotentiating nano-chitosan as potent vaccine carter for efficacious prophylaxis of filarial antigens.
Malathi B; Mona S; Thiyagarajan D; Kaliraj P
Int J Biol Macromol; 2015 Feb; 73():131-7. PubMed ID: 25433130
[TBL] [Abstract][Full Text] [Related]
3. Development of a liposomal nanodelivery system for nevirapine.
Ramana LN; Sethuraman S; Ranga U; Krishnan UM
J Biomed Sci; 2010 Jul; 17(1):57. PubMed ID: 20624325
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and structural characterizations of thioredoxin reductase selenoproteins of the parasitic filarial nematodes Brugia malayi and Onchocerca volvulus.
Fata F; Gencheva R; Cheng Q; Lullo R; Ardini M; Silvestri I; Gabriele F; Ippoliti R; Bulman CA; Sakanari JA; Williams DL; Arnér ESJ; Angelucci F
Redox Biol; 2022 May; 51():102278. PubMed ID: 35276442
[TBL] [Abstract][Full Text] [Related]
5. Prediction of Brugia malayi antigenic peptides: candidates for synthetic vaccine design against lymphatic filariasis.
Gomase VS; Chitlange NR; Changbhale SS; Kale KV
Protein Pept Lett; 2013 Aug; 20(8):864-87. PubMed ID: 23537185
[TBL] [Abstract][Full Text] [Related]
6. Thioredoxin from Brugia malayi: defining a 16-kilodalton class of thioredoxins from nematodes.
Kunchithapautham K; Padmavathi B; Narayanan RB; Kaliraj P; Scott AL
Infect Immun; 2003 Jul; 71(7):4119-26. PubMed ID: 12819103
[TBL] [Abstract][Full Text] [Related]
7. Immune responses of B. malayi thioredoxin (TRX) and venom allergen homologue (VAH) chimeric multiple antigen for lymphatic filariasis.
Anugraha G; Jeyaprita PJ; Madhumathi J; Sheeba T; Kaliraj P
Acta Parasitol; 2013 Dec; 58(4):468-77. PubMed ID: 24338307
[TBL] [Abstract][Full Text] [Related]
8. Bma-LAD-2, an Intestinal Cell Adhesion Protein, as a Potential Therapeutic Target for Lymphatic Filariasis.
Flynn AF; Taylor RT; Pazgier ME; Bennuru S; Lindrose AR; Sterling SL; Morris CP; Gleeson BI; Maugel TK; Nutman TB; Mitre E
mBio; 2022 Jun; 13(3):e0374221. PubMed ID: 35475643
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary liposomal formulations encapsulated procaterol hydrochloride by a remote loading method achieve sustained release and extended pharmacological effects.
Tahara K; Tomida H; Ito Y; Tachikawa S; Onodera R; Tanaka H; Tozuka Y; Takeuchi H
Int J Pharm; 2016 May; 505(1-2):139-46. PubMed ID: 27012982
[TBL] [Abstract][Full Text] [Related]
10. Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice.
Mayer LD; Tai LC; Ko DS; Masin D; Ginsberg RS; Cullis PR; Bally MB
Cancer Res; 1989 Nov; 49(21):5922-30. PubMed ID: 2790807
[TBL] [Abstract][Full Text] [Related]
11. Preparation of Barije (Ferula gummosa) Essential Oil-Loaded Liposomes and Evaluation of Physical and Antibacterial Effect on Escherichia coli O157:H7.
Najaf Najafi M; Arianmehr A; Sani AM
J Food Prot; 2020 Mar; 83(3):511-517. PubMed ID: 32073614
[TBL] [Abstract][Full Text] [Related]
12. Physicochemical characteristics of liposome encapsulation of stingless bees' propolis.
Ramli NA; Ali N; Hamzah S; Yatim NI
Heliyon; 2021 Apr; 7(4):e06649. PubMed ID: 33898810
[TBL] [Abstract][Full Text] [Related]
13. Humans from Wuchereria bancrofti endemic area elicit substantial immune response to proteins of the filarial parasite Brugia malayi and its endosymbiont Wolbachia.
Jha R; Gangwar M; Chahar D; Setty Balakrishnan A; Negi MP; Misra-Bhattacharya S
Parasit Vectors; 2017 Jan; 10(1):40. PubMed ID: 28118850
[TBL] [Abstract][Full Text] [Related]
14. Preclinical study of Doxorubicine-loaded liposomal drug delivery for the treatment of head and neck cancer: Optimization by Box-Behnken statistical design.
Yang B
Acta Biochim Pol; 2020 Jun; 67(2):149-155. PubMed ID: 32506868
[TBL] [Abstract][Full Text] [Related]
15. A study on the role of cholesterol and phosphatidylcholine in various features of liposomal doxorubicin: From liposomal preparation to therapy.
Farzaneh H; Ebrahimi Nik M; Mashreghi M; Saberi Z; Jaafari MR; Teymouri M
Int J Pharm; 2018 Nov; 551(1-2):300-308. PubMed ID: 30243944
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of nematode specific protective epitopes of Brugia malayi TRX towards development of synthetic vaccine construct for lymphatic filariasis.
Madhumathi J; Prince PR; Anugraha G; Kiran P; Rao DN; Reddy MV; Kaliraj P
Vaccine; 2010 Jul; 28(31):5038-48. PubMed ID: 20653106
[TBL] [Abstract][Full Text] [Related]
17. Incorporation of white tea extract in nano-liposomes: optimization, characterization, and stability.
Ahmadi E; Elhamirad AH; Mollania N; Saeidi Asl MR; Pedramnia A
J Sci Food Agric; 2022 Mar; 102(5):2050-2060. PubMed ID: 34562028
[TBL] [Abstract][Full Text] [Related]
18. Improved oral bioavailability of breviscapine via a Pluronic P85-modified liposomal delivery system.
Zhou Y; Ning Q; Yu DN; Li WG; Deng J
J Pharm Pharmacol; 2014 Jul; 66(7):903-11. PubMed ID: 24697705
[TBL] [Abstract][Full Text] [Related]
19. Co-delivery of doxorubicin and PSC 833 (Valspodar) by stealth nanoliposomes for efficient overcoming of multidrug resistance.
Bajelan E; Haeri A; Vali AM; Ostad SN; Dadashzadeh S
J Pharm Pharm Sci; 2012; 15(4):568-82. PubMed ID: 23106959
[TBL] [Abstract][Full Text] [Related]
20. Nanocurcumin: a novel antifilarial agent with DNA topoisomerase II inhibitory activity.
Ali M; Afzal M; Abdul Nasim S; Ahmad I
J Drug Target; 2014 Jun; 22(5):395-407. PubMed ID: 24479705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
